Politician trade (House)

Danaher Corporation (DHR): Rep. Val T. Hoyle (OR04) disclosed a purchase $1K–$15K

Rep. Val T. Hoyle (OR04) disclosed a purchase of Danaher Corporation in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
318 days
Disclosure lag
Traded
Oct 29, 2024
Disclosed
Sep 12, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

    What came next

    1. Nov 13, 2024FDARecall: DxI 9000 Access Immunoassay Analyzer, Catalog Number C11137
    2. Nov 18, 2024FDARecall: Access hsTnI Reagent, REF B52699, Immunoassay Method, Troponin Subunit. For the quantitative determination of cardiac troponin I (cTnI) levels in human serum a…
    3. Nov 25, 2024InsiderOfficer sold ~$1.99M of DHR shares in the open market
    4. Nov 26, 2024FDARecall: Access Intact PTH assay, a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of intact parathyroid hormone (parathyrin, PT…
    5. Nov 26, 2024InsiderOfficer sold ~$6.23M of DHR shares in the open market
    6. Dec 13, 2024FDAFDA device clearance: ABL90 FLEX PLUS System
    7. Jan 2, 2025FDARecall: Access PCT Reagent Pack, Catalog Number C53987, when used on Access 2 and UniCel Dxl Immunoassay Systems
    8. Jan 10, 2025FDAFDA device clearance: Xpert Xpress CoV-2/Flu/RSV plus
    9. Jan 10, 2025FDARecall: DxC 500 AU Clinical Chemistry Analyzer, REF: C63519, and C63520 with affected software.
    10. Jan 14, 2025FDAFDA device clearance: ABL90 FLEX PLUS System
    11. Jan 15, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
    12. Jan 30, 2025FDARecall: Brand Name: Leica Biosystems Cryostats Product Name: CM1950 Model/Catalog Number: 1491950C4US Software Version: firmware V3.01
    13. Jan 30, 2025InsiderOfficer sold ~$1.28M of DHR shares in the open market
    14. Feb 3, 2025FDARecall: Access Erythropoietin (EPO), Catalog Number - A16364 a glycoprotein (~30,400 Daltons) produced primarily by the kidney, is the principal factor regulating red…
    15. Feb 5, 2025FDARecall: Access 2 Immunoassay Analyzer, Catalog Number 81600N
    16. Feb 5, 2025FDARecall: DxI 9000 Access Immunoassay Analyzer, Catalog Number C11137.
    17. Feb 6, 2025FDARecall: DxI 9000 Access Immunoassay Analyzer, Catalog Number C11137, with Component PCB, TSI/RSI firmware C29278
    18. Feb 7, 2025InsiderDirector sold ~$114K of DHR shares in the open market
    19. Feb 21, 2025FDAFDA device clearance: Xpert® FII & FV
    20. Feb 26, 2025FDARecall: DxC 500 AU Clinical Chemistry Analyzer, Catalog Numbers/UDI codes: C63519 / 14987666545058 C63520 / 14987666545065 The Beckman Coulter DxC 500 AU Clinical Chem…
    View the official recordHouse Clerk periodic transaction report

    How to read House Clerk periodic transaction report

    The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

    Full guide: What is the STOCK Act?

    What else is on file for Danaher Corporation

    For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 2 fund holdings reports (13F) dated in the last 90 days.

    These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

    Other recent filings by Rep. Val T. Hoyle (OR04)

    The full history of Rep. Val T. Hoyle (OR04) is on the profile page.

    How this filing works

    Explore the data

    Other disclosures at Danaher Corporation

    Everything OQRO holds on this company is on its DHR page.

    This is one filing. OQRO holds the rest

    Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

    OQRO is free for everyone. No card, no trial

    OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data